These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26688528)

  • 1. Factors associated with recurrent tuberculosis more than 12 months after treatment completion.
    Kim L; Moonan PK; Heilig CM; Yelk Woodruff RS; Kammerer JS; Haddad MB
    Int J Tuberc Lung Dis; 2016 Jan; 20(1):49-56. PubMed ID: 26688528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking increases risk of recurrence after successful anti-tuberculosis treatment: a population-based study.
    Yen YF; Yen MY; Lin YS; Lin YP; Shih HC; Li LH; Chou P; Deng CY
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):492-8. PubMed ID: 24670708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.
    Dangisso MH; Woldesemayat EM; Datiko DG; Lindtjørn B
    PLoS One; 2018; 13(3):e0193396. PubMed ID: 29529036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.
    Verver S; Warren RM; Beyers N; Richardson M; van der Spuy GD; Borgdorff MW; Enarson DA; Behr MA; van Helden PD
    Am J Respir Crit Care Med; 2005 Jun; 171(12):1430-5. PubMed ID: 15831840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of recurrent tuberculosis in the United States, 1993-2010.
    Kim L; Moonan PK; Yelk Woodruff RS; Kammerer JS; Haddad MB
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):357-60. PubMed ID: 23321472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments.
    Fletcher R; Jones JD; Shah NS
    PLoS One; 2016; 11(10):e0164162. PubMed ID: 27732650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.
    Karo B; Hauer B; Hollo V; van der Werf MJ; Fiebig L; Haas W
    Euro Surveill; 2015; 20(49):. PubMed ID: 26676247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with extended treatment among tuberculosis patients at risk of relapse in California.
    Qin F; Barry PM; Pascopella L
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):363-9. PubMed ID: 27046718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of tuberculosis among patients following treatment completion in eight provinces of Vietnam: A nested case-control study.
    Bestrashniy JRBM; Nguyen VN; Nguyen TL; Pham TL; Nguyen TA; Pham DC; Nghiem LPH; Le TNA; Nguyen BH; Nguyen KC; Nguyen HD; Buu TN; Le TN; Nguyen VH; Dinh NS; Britton WJ; Marks GB; Fox GJ
    Int J Infect Dis; 2018 Sep; 74():31-37. PubMed ID: 29944930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis recurrences and predictive factors in a vulnerable population in Catalonia.
    Brugueras S; Molina VI; Casas X; González YD; Forcada N; Romero D; Rodés A; Altet MN; Maldonado J; Martin-Sánchez M; Caylà JA; Orcau À; Rius C; Millet JP
    PLoS One; 2020; 15(1):e0227291. PubMed ID: 31940383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China.
    Ruan QL; Yang QL; Sun F; Liu W; Shen YJ; Wu J; Jiang N; Zhou JY; Shao LY; Zhang WH
    Clin Microbiol Infect; 2022 May; 28(5):684-689. PubMed ID: 34601149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completion of tuberculosis therapy for patients reported in the United States in 1993.
    Bloch AB; Cauthen GM; Simone PM; Kelly GD; Dansbury KG; Castro KG
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):273-80. PubMed ID: 10206496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality after anti-tuberculosis treatment completion: results of long-term follow-up.
    Shuldiner J; Leventhal A; Chemtob D; Mor Z
    Int J Tuberc Lung Dis; 2016 Jan; 20(1):43-8. PubMed ID: 26688527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
    Farah MG; Tverdal A; Steen TW; Heldal E; Brantsaeter AB; Bjune G
    BMC Public Health; 2005 Feb; 5():14. PubMed ID: 15698472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment.
    Hang NT; Maeda S; Keicho N; Thuong PH; Endo H
    Tuberculosis (Edinb); 2015 May; 95(3):336-42. PubMed ID: 25732626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.